These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20804504)

  • 21. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
    Junquera L; Gallego L
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
    [No Abstract]   [Full Text] [Related]  

  • 23. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 24. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
    Gueiros LA; Lopes MA; Leão JC
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809
    [No Abstract]   [Full Text] [Related]  

  • 25. Study finds no link between bone drugs and unusual thigh fractures.
    Harv Womens Health Watch; 2010 Jul; 17(11):6. PubMed ID: 20684079
    [No Abstract]   [Full Text] [Related]  

  • 26. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws.
    Oreadi D; Papageorge MB
    J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801
    [No Abstract]   [Full Text] [Related]  

  • 28. Zoledronic acid induced osteonecrosis of tibia and femur.
    Gupta S; Jain P; Kumar P; Parikh PM
    Indian J Cancer; 2009; 46(3):249-50. PubMed ID: 19574685
    [No Abstract]   [Full Text] [Related]  

  • 29. More on atypical fractures of the femoral diaphysis.
    Lee P; Seibel MJ
    N Engl J Med; 2008 Jul; 359(3):317; author reply 317-8. PubMed ID: 18642421
    [No Abstract]   [Full Text] [Related]  

  • 30. Bisphosphonate associated osteonecrosis of the jaws and endodontic treatment: two case reports.
    Fugazzotto PA; Lightfoot S
    J Mass Dent Soc; 2006; 55(2):5. PubMed ID: 16937899
    [No Abstract]   [Full Text] [Related]  

  • 31. Boning up on osteoporosis medications.
    Johns Hopkins Med Lett Health After 50; 2010 May; 22(3):1-2, 7. PubMed ID: 20518136
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 33. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 34. Annual zoledronic acid for osteoporosis.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
    Ringe JD
    MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
    [No Abstract]   [Full Text] [Related]  

  • 37. [Maxillary osteonecrosis associated with bisphosphonates].
    Madrid C
    Rev Med Suisse; 2006 Nov; 2(86):2575-6. PubMed ID: 17168049
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous bisphosphonates in osteoporosis and jaw osteonecrosis: comment on the article by Delmas et al.
    Landis BN; Hugentobler M
    Arthritis Rheum; 2006 Nov; 54(11):3720-1; author reply 3721-2. PubMed ID: 17075888
    [No Abstract]   [Full Text] [Related]  

  • 39. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

  • 40. Case of maxillary avascular necrosis due to oral bisphosphonates, presenting with signs of malignancy.
    Green R; Blackmore K; Robson A
    J Laryngol Otol; 2010 Dec; 124(12):1318-20. PubMed ID: 20441673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.